000 01387 a2200421 4500
005 20250515185228.0
264 0 _c20090928
008 200909s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/WNL.0b013e3181b78460
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMenge, T
245 0 0 _aInterferon beta treatment does not induce organ-specific autoantibodies in multiple sclerosis.
_h[electronic resource]
260 _bNeurology
_cSep 2009
300 _a900-2 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAutoantibodies
_ximmunology
650 0 4 _aAutoantigens
_ximmunology
650 0 4 _aFemale
650 0 4 _aGlutamate Decarboxylase
_ximmunology
650 0 4 _aHumans
650 0 4 _aInterferon-beta
_ximmunology
650 0 4 _aIodide Peroxidase
_ximmunology
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Sclerosis
_xdrug therapy
650 0 4 _aPeptide Fragments
_ximmunology
650 0 4 _aThyroglobulin
_ximmunology
700 1 _aSchloot, N C
700 1 _aSchott, M
700 1 _aHemmer, B
700 1 _aWiendl, H
700 1 _aRoden, M
700 1 _aHartung, H-P
700 1 _aKieseier, B C
773 0 _tNeurology
_gvol. 73
_gno. 11
_gp. 900-2
856 4 0 _uhttps://doi.org/10.1212/WNL.0b013e3181b78460
_zAvailable from publisher's website
999 _c19150422
_d19150422